A Comprehensive Guide to Immunotherapy Drugs
This section provides detailed information on all immunotherapy drugs currently approved by the FDA for cancer treatment. We have broken down each immunotherapy drug, including Care Step pathways, healthcare provider resources, as well as providing information for deeper understanding of the different types of immunotherapies available. Whether you’re a community-based practitioner or an oncologist at a research institution, this section is designed to ensure the best outcomes for your patients.
What is Immunotherapy?
Immunotherapy is a cutting-edge treatment approach that uses the immune system to fight cancer. It encompasses a wide range of therapies, including immune checkpoint inhibitors, monoclonal antibodies, cytokines, CAR T-cell therapy, antibody-drug conjugates, and vaccines. By either enhancing or suppressing immune system responses, immunotherapy helps to regenerate immune recognition of cancer cells, interfere with checkpoint controls, and leverage the body’s natural immunology to target tumors.
Types of Immunotherapy:
- Antibody-Drug Conjugates
- Bispecific Antibodies
- BiTEs
- CAR T-Cell Therapy
- Cytokines/Immune System Modulators
- Immune Checkpoint Inhibitors
- Monoclonal Antibodies
- Tumor-Infiltrating Lymphocytes
- Vaccines
As new immunotherapies receive FDA approval each year, this section is continuously updated to reflect the latest advancements and provide you with the most current information.
Provider Resources
Each immunotherapy drug is accompanied by a comprehensive provider toolkit, which includes detailed information on:
- Drug Dosing and Administration
- Notable Toxicities and Management of irAEs (Immune-Related Adverse Effects)
- Clinical Pearls and Best Practices
- Patient and Healthcare Provider Educational Resources
- Q&A Sections to Address Common Concerns
These toolkits are designed to be easily accessible, downloadable, and printable, ensuring that you have the resources you need, whenever you need them.
AIM with Immunotherapy’s Mission
Our mission is to provide healthcare providers with the latest immunotherapy knowledge and resources to help patients achieve the best possible outcomes. Through education, resource sharing, and continual updates on new FDA-approved treatments, AIM with Immunotherapy is committed to ensuring that you have access to the most current information in the field of cancer immunotherapy.
We hope this section serves as a valuable resource to aid your clinical practice and ultimately improve the lives of the patients you care for.